NASDAQ false 0001814329 --12-31 0001814329 2024-07-18 2024-07-18

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 18, 2024

 

 

Astra Space, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39426   85-1270303
(State or Other Jurisdiction
of Incorporation)
 

(Commission

File Number)

  (IRS Employer
Identification No.)

 

1900 Skyhawk Street  
Alameda, California   94501
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s Telephone Number, Including Area Code: (510) 956-5279

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Class A common stock, par value $0.0001 per share   ASTR   Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Introduction

On July 18, 2024 (the “Closing Date”), Astra Space, Inc. (the “Company”) completed its previously announced merger with Apogee Merger Sub Inc., a Delaware corporation (“Merger Sub”) and wholly owned subsidiary of Apogee Parent Inc., a Delaware corporation (“Parent”). Pursuant to the terms and subject to the conditions set forth in the Agreement and Plan of Merger (the “Merger Agreement”), dated as of March 7, 2024, by and among, the Company, Parent and Merger Sub, the Company merged with and into Merger Sub with the Company surviving the merger as a subsidiary of Parent (the “Surviving Corporation” and such merger, the “Merger”).

The description of the Merger Agreement and related transactions (including, without limitation, the Merger) in this Current Report on Form 8-K (this “Current Report”) does not purport to be complete and is subject to and qualified in its entirety by reference to the full text of the Merger Agreement, a copy of which is filed as Exhibit 2.1 to the Company’s Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 12, 2024, and incorporated herein by reference.

 

Item 1.01.

Entry into a Material Definitive Agreement.

Immediately after the effective time of the Merger (the “Effective Time”), all outstanding 12.0% senior secured convertible notes due 2025 (the “Company Convertible Notes”), that, prior to the Effective Time, were convertible into shares of Class A common stock, par value $0.0001 per share, of the Company (the “Class A Shares”), were converted into shares of Series A preferred stock, par value $0.0001 per share, of Parent (the “Parent Series A Preferred Stock”) and cancelled and all of Company’s obligations under or with respect to such convertible notes were fully satisfied and discharged. The Company Convertible Notes were issued by the Company pursuant to that certain Securities Purchase Agreement dated as of August 4, 2023 (as amended or otherwise modified by, inter alia, that certain Reaffirmation Agreement and Omnibus Amendment Agreement dated as of November 6, 2023, that certain Omnibus Amendment No. 3 Agreement dated as of November 21, 2023, that certain Amendment to Securities Purchase Agreement dated as of January 19, 2024, that certain Amendment to Senior Secured Convertible Notes dated as of January 31, 2024, that certain Second Amendment to Securities Purchase Agreement and Second Amendment to Senior Secured Convertible Notes dated as of February 26, 2024, that certain Limited Waiver and Consent to Senior Secured Convertible Notes and Common Stock Purchase Warrant and Reaffirmation of Transaction Documents, dated as of March 7, 2024, that certain Third Amendment to Securities Purchase Agreement and Third Amendment to Senior Secured Convertible Notes dated as of April 15, 2024, that certain Fourth Amendment to Senior Secured Convertible Notes dated as of May 1, 2024 and that certain Fifth Amendment to Senior Secured Convertible Notes dated as of May 31, 2024) (as so amended and modified, the “Purchase Agreement”). In connection with the conversion of the Company Convertible Notes, the Company, each of the subsidiaries of the Company (together with the Company, the “Note Parties”), GLAS Americas LLC, as collateral agent (the “Collateral Agent”), JMCM Holdings LLC (“JMCM”), SherpaVentures Fund II, LP (“ACME Fund II”), Chris Kemp, trustee of the Chris Kemp Living Trust dated February 10, 2021 (the “Kemp Trust”), Adam P. London, MH Orbit LLC (“MH Orbit”) and RBH Ventures Astra SPV, LLC (“RBH”), Astera Institute (“Astera”), ERAS Capital, LLC (“ERAS”), Ulrich Gall, Chenel Capital Partners LLC (“Chenel Capital”) and Richard Delmas Breezy Wynn (Mr. Wynn, collectively with JMCM, ACME Fund II, the Kemp Trust, Mr. London, MH Orbit, RBH, Astera, ERAS, Mr. Gall and Chenel Capital, the “Noteholders”) entered into an Omnibus Termination Agreement, dated as of July 18, 2024 (the “Termination Agreement”).

Pursuant to the Termination Agreement, the Note Parties and the Noteholders agreed to terminate the Purchase Agreement and release and terminate all security agreements with respect to the collateral thereunder.

The description of the Termination Agreement and related transactions in this Current Report does not purport to be complete and is subject to and qualified in its entirety by reference to the full text of the Termination Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report and incorporated herein by reference.

 

Item 2.01.

Completion of Acquisition or Disposition of Assets.

The information set forth in the Introduction, under Item 1.01, Item 3.03, Item 5.01, Item 5.02 and Item 5.03 of this Current Report is incorporated by reference into this Item 2.01.

On July 18, 2024, pursuant to the terms of the Merger Agreement, the Merger was effected, with Merger Sub being merged with and into the Company, and the Company surviving the Merger as a wholly-owned subsidiary of Parent. At the Effective Time, each Class A Share issued and outstanding immediately prior to the Effective Time (other than Rollover Shares (as defined below), any Class A Shares canceled pursuant to the terms of the Merger Agreement and any dissenting Class A Shares) was converted into the right to receive an amount in cash equal to $0.50 per Class A Share, without interest (the “Merger Consideration”).

Immediately prior to the Effective Time, each share of Class B common stock, par value $0.0001 per share (the “Class B Shares”), all of which Class B Shares were held by the Company’s co-founders, Chris C. Kemp, the Company’s chief executive officer, chairman and a director, and Dr. Adam P. London, the Company’s chief technology officer and a director (collectively, including the Chris Kemp Living Trust dated February 10, 2021, the “Specified Stockholders”), was converted into an equal number of Class A Shares.


At the Effective Time, all Class A Shares held by Parent or its affiliates, including the Specified Stockholders (other than 160,000 Class A Shares held by the Specified Stockholders that were excluded from their respective rollover agreements to cover transaction expenses in connection with the Merger and were converted into the right to receive the Merger Consideration), and certain other holders of Class A Shares (the “Rollover Shares”), as a result of having been acquired by Parent or its affiliates pursuant to a rollover agreement or in connection with the funding of a capital commitment set forth in an equity commitment letter, were canceled without payment of any consideration therefor and cease to exist. In exchange for the delivery of such Rollover Shares to Parent, such holders of Rollover Shares were issued shares of Parent Series A Preferred Stock. In total, 6.712.110 Class A Shares were rolled over to Parent Series A Preferred Stock.

Immediately prior to the Effective Time, all outstanding options to purchase Class A Shares had an exercise price equal to or greater than the Merger Consideration, and in accordance with the Merger Agreement, were canceled at the Effective Time for no consideration and cease to exist.

Immediately prior to the Effective Time, each outstanding restricted stock unit with respect to Class A Shares (a “Company RSU Award”) that had vested in accordance its terms was cancelled in exchange for the right to receive an amount in cash equal to the product obtained by multiplying (a) the aggregate number of Class A Shares subject to such Company RSU Award by (b) the Merger Consideration, without interest and less required tax withholdings. At the Effective Time, each Company RSU Award that had not vested in accordance with its terms was canceled for no consideration and cease to exist.

Immediately after the Effective Time, (a) all outstanding Company Convertible Notes, were converted into shares of Parent Series A Preferred Stock and cancelled and all of Company’s obligations under or with respect to the Company Convertible Notes were fully satisfied and discharged; and (b) all outstanding warrants to purchase Class A common stock, dated August 4, 2023, and common stock purchase warrants, dated November 6, 2023, November 13, 2023, November 21, 2023, January 19, 2024, March 6, 2024, March 7, 2024, March 15, 2024, May 13, 2024, June 28, 2024 and July 3, 2024, in each case, issued by the Company in favor of the respective holders thereof, were exchanged for warrants to purchase Parent Series A Preferred Stock.

The aggregate consideration paid to holders of Class A Shares pursuant to the Merger Agreement was approximately $8.1 million. The foregoing description does not purport to be complete and is subject to and qualified in its entirety by reference to the full text of the Merger Agreement, which is included as Exhibit 2.1 to the Current Report on Form 8-K filed with the SEC by the Company on March 12, 2024 and is incorporated herein by reference.

A copy of the press release issued by the Company on the Closing Date announcing the completion of the Merger is filed herewith as Exhibit 99.1 and is incorporated by reference into this Item 2.01.

 

Item 3.01.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

The information set forth in the Introduction, under Item 2.01 and Item 3.03 of this Current Report is incorporated by reference into this Item 3.01.

Prior to the opening of trading on July 18, 2024, the Company notified the Nasdaq Capital Market (“Nasdaq”) that the Merger had been completed and that the Certificate of Merger had been filed, and requested that Nasdaq suspend trading of the Class A Shares on Nasdaq prior to the opening of trading on July 18, 2024. The Company also requested that Nasdaq file with the SEC a notification of removal from listing and registration on Form 25 to effect the delisting of all Class A Shares from Nasdaq and deregistration of such Class A Shares under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). As a result, Class A Shares will no longer be listed on Nasdaq. In addition, the Company intends to file a certification on Form 15 with the SEC requesting suspension of the Company’s reporting obligations under Sections 13 and 15(d) of the Exchange Act with respect to all common stock of the Company and post-effective amendments to its registration statements on Forms S-3 and S-8, terminating the registration of the Class A Shares underlying such registration statements.

As previously disclosed, (i) on April 17, 2024, the Company received a deficiency notice from Nasdaq that the Company is not in compliance with Nasdaq Listing Rule 5450(a)(1) because the per share closing bid price of the Class A Shares had been below $1.00 for thirty consecutive business days prior to such deficiency notice; and (ii) on April 23, 2024, the Company received a deficiency notice from Nasdaq that the Company is not in compliance with the minimum stockholders’ equity listing requirement set forth in Nasdaq Listing Rule 5550(b)(1) because the Company’s Annual Report on Form 10-K for the period ended December 31, 2023, reported stockholders’ equity below $2.5 million.

 

Item 3.03.

Material Modifications to Rights of Security Holders.

The information set forth in the Introduction, under Item 2.01, Item 3.01, Item 5.01 and Item 5.03 of this Current Report is incorporated by reference into this Item 3.03.

Pursuant to the Merger Agreement and in connection with the consummation of the Merger, each Class A Share (other than Rollover Shares as described in Item 2.01 above) was canceled and automatically converted into the right to receive the Merger Consideration.


Item 5.01.

Changes in Control of Registrant.

The information set forth in the Introduction, under Item 2.01, Item 3.03 and Item 5.03 of this Current Report is incorporated by reference into this Item 5.01.

As a result of the consummation of the Merger, a change of control of the Company occurred, and the Company became a subsidiary of Parent.

 

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

The information set forth in the Introduction and under Item 2.01 of this Current Report is incorporated by reference into this Item 5.02.

At the Effectve Time, (a) the directors of Merger Sub immediately prior to the completion of the Merger continued as the directors of the Surviving Corporation; and (b) the officers of the Company immediately prior to the completion of the Merger continued as the officers of the Surviving Corporation.

 

Item 5.03.

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

Pursuant to the terms of the Merger Agreement, at the Effective Time, the certificate of incorporation of the Company, as in effect immediately prior to the Effective Time, was amended and restated in its entirety (the “Amended and Restated Certificate of Incorporation”) and the bylaws of Merger Sub in effect immediately prior to the Effective Time became the bylaws of the Surviving Corporation, except that references to Merger Sub’s name were replaced with references to the Surviving Company’s name (the “Amended and Restated Bylaws”).

Copies of the Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws are filed as Exhibit 3.1 and Exhibit 3.2, respectively, each of which is incorporated herein by reference.

 

Item 8.01.

Other Events.

On July 18, 2024, the Company issued a press release announcing the closing of the Merger. A copy of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit
No.

  

Description

 2.1*    Agreement and Plan of Merger, dated as of March 7, 2024, by and among Astra Space, Inc., Apogee Parent Inc. and Apogee Merger Sub Inc. (incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed with the SEC on March 12, 2024).
 3.1    Amended and Restated Certificate of Incorporation of Astra Space, Inc., dated as of July 18, 2024.
 3.2    Amended and Restated Bylaws of Astra Space, Inc., dated as of July 18, 2024.
10.1*    Omnibus Termination Agreement, dated as of July 18, 2024, by and among Astra Space, Inc., each of the subsidiaries of Astra Space, Inc. party thereto, each of the investors party thereto, and GLAS Americas, LLC, as collateral agent.
99.1    Press Release dated as of July 18, 2024.
104    Cover Page Interactive Data File (embedded with Inline XBRL document).

 

*

Non-material schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish supplemental copies of any of the omitted schedules and exhibits upon request by the SEC.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: July 18, 2024     ASTRA SPACE, INC.
    By:  

/s/ Axel Martinez

    Name:   Axel Martinez
    Title:   Chief Financial Officer

Exhibit 3.1

THIRD AMENDED AND RESTATED

CERTIFICATE OF INCORPORATION

OF

ASTRA SPACE, INC.

ARTICLE I

The name of the corporation is Astra Space, Inc. (the “Company”).

ARTICLE II

The registered agent and the address of the registered office in the State of Delaware are:

Corporation Service Company

251 Little Falls Drive

Wilmington, Delaware 19808

County of New Castle

ARTICLE III

The purpose of the Company is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of Delaware.

ARTICLE IV

The aggregate number of shares which the Company shall have authority to issue is one hundred (100) shares of capital stock, all of which shall be designated “Common Stock” and have a par value of $0.0001 per share.

ARTICLE V

In furtherance of and not in limitation of the powers conferred by the laws of the State of Delaware, the board of directors of the Company (the “Board of Directors”) is expressly authorized to make, amend or repeal bylaws of the Company (the “Bylaws”).

ARTICLE VI

The business and affairs of the Company shall be managed by or under the direction of the Board of Directors. Elections of directors need not be by written ballot unless otherwise provided in the Bylaws of the Company.


ARTICLE VII

(A) To the fullest extent permitted by the General Corporation Law of Delaware, as it exists or as may hereafter be amended, no current or former director or officer of the Company or any predecessor of the Company shall be personally liable to the Company or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, as applicable; provided, however, that nothing contained in this ARTICLE VII shall eliminate or limit the liability of a director or officer (i) for any breach of the director’s or officer’s duty of loyalty to the Company or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) pursuant to the provisions of Section 174 of the General Corporation Law of Delaware, provided that this clause (iii) shall be applicable to directors only, (iv) for any transaction from which the director or officer derived an improper personal benefit, or (v) for any action by, or in the right of, the Company, provided, that this clause (v) shall be applicable to officers only.

(B) The Company is authorized to indemnify, and advance expenses to, to the fullest extent permitted by law any person made or threatened to be made a party to any threatened, pending or completed action or proceeding, whether criminal, civil, administrative or investigative, by reason of the fact that such person is or was a director, officer, employee or agent of the Company or any predecessor of the Company, or serves or served at any other enterprise as a director, officer, employee or agent at the request of the Company or any predecessor to the Company.

(C) Neither any amendment nor repeal of this ARTICLE VII, nor the adoption of any provision of the Company’s Certificate of Incorporation inconsistent with this ARTICLE VII, shall eliminate or reduce the effect of this ARTICLE VII in respect of any matter occurring, or any action or proceeding accruing or arising or that, but for this ARTICLE VII, would accrue or arise, prior to such amendment, repeal or adoption of an inconsistent provision.

ARTICLE VIII

The Company expressly elects not to be governed by Section 203 of the General Corporation Law of Delaware.

ARTICLE IX

Unless the Company consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Company, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Company to the Company or the Company’s stockholders, (iii) any action asserting a claim arising pursuant to any provision of the General Corporation Law of Delaware, or (iv) any action asserting a claim governed by the internal affairs doctrine. Any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of the Company shall be deemed to have notice of and consented to the provisions of this ARTICLE IX.


CERTIFICATE OF SECRETARY

The undersigned hereby certifies that the undersigned is the duly elected, qualified, and acting Secretary or Assistant Secretary of Astra Space, Inc., a Delaware corporation, and that the foregoing Third Amended and Restated Certificate of Incorporation was adopted as the Certificate of Incorporation of the Company on July 18, 2024, by the person appointed in this certificate of incorporation to act as the Incorporator.

Executed on July 18, 2024.

 

/s/ Matthew Sant
Matthew Sant, Corporate Secretary

Exhibit 3.2

BYLAWS

OF

ASTRA SPACE, INC.


TABLE OF CONTENTS

 

               Page  

Article I Corporate Offices

     1  
   1.1   

Principal Office

     1  
   1.2   

Other Offices

     1  

Article II Meetings of Stockholders

     1  
   2.1   

Place Of Meetings

     1  
   2.2   

Annual Meeting

     1  
   2.3   

Special Meeting

     1  
   2.4   

Notice of Stockholders’ Meetings

     2  
   2.5   

Manner of Giving Notice; Affidavit of Notice

     2  
   2.6   

Quorum

     2  
   2.7   

Adjourned Meeting; Notice

     2  
   2.8   

Organization; Conduct of Business

     2  
   2.9   

Voting

     3  
   2.10   

Waiver of Notice

     3  
   2.11   

Stockholder Action by Written Consent Without a Meeting

     3  
   2.12   

Record Date for Stockholder Notice, Voting and Consents

     4  
   2.13   

Proxies

     4  
   2.14   

Meetings by Telephone or Similar Communications

     5  
   2.15   

Ratification of Acts of Directors and Officers

     5  

Article III Directors

     5  
   3.1   

Powers

     5  
   3.2   

Number of Directors

     5  
   3.3   

Election, Qualification and Term of Office of Directors

     6  
   3.4   

Resignation and Vacancies

     6  
   3.5   

Place of Meetings; Meetings by Telephone

     7  
   3.6   

Regular Meetings

     7  
   3.7   

Special Meetings; Notice

     7  
   3.8   

Quorum

     7  
   3.9   

Waiver of Notice

     7  
   3.10   

Board Action by Written Consent Without a Meeting

     8  
   3.11   

Fees and Compensation of Directors

     8  
   3.12   

Removal of Directors

     8  

Article IV Committees

     8  
   4.1   

Committees of Directors

     8  
   4.2   

Committee Minutes

     9  
   4.3   

Meetings and Action of Committees

     9  

Article V Officers

     9  
   5.1   

Officers

     9  
   5.2   

Appointment of Officers

     9  
   5.3   

Subordinate Officers

     9  
   5.4   

Removal and Resignation of Officers

     9  
   5.5   

Vacancies in Offices

     10  

 

-i-


TABLE OF CONTENTS

(continued)

 

               Page  
   5.6   

Chairman of the Board

     10  
   5.7   

Chief Executive Officer

     10  
   5.8   

President

     10  
   5.9   

Vice Presidents

     10  
   5.10   

Secretary

     10  
   5.11   

Chief Financial Officer

     11  
   5.12   

Assistant Secretary

     11  
   5.13   

Treasurer

     11  
   5.14   

Representation of Shares of Other Corporations

     11  
   5.15   

Authority and Duties of Officers

     11  

Article VI Indemnification of Directors, Officers, Employees and Other Agents

     12  
   6.1   

Right to Indemnification

     12  
   6.2   

Right to Advancement of Expenses

     12  
   6.3   

Right of Indemnitee to Bring Suit

     12  
   6.4   

Non-Exclusivity of Rights

     13  
   6.5   

Insurance

     13  
   6.6   

Indemnification of Other Persons

     13  
   6.7   

Amendments

     13  
   6.8   

Certain Definitions

     14  
   6.9   

Contract Rights

     14  
   6.10   

Severability

     14  

Article VII Records and Reports

     14  
   7.1   

Maintenance and Inspection of Records

     14  
   7.2   

Inspection by Directors

     15  

Article VIII General Matters

     15  
   8.1   

Checks

     15  
   8.2   

Deposits

     15  
   8.3   

Execution of Corporate Contracts and Instruments

     15  
   8.4   

Stock Certificates; Partly Paid Shares

     15  
   8.5   

Special Designation on Certificates

     16  
   8.6   

Lost Certificates

     16  
   8.7   

Construction; Definitions

     16  
   8.8   

Dividends

     17  
   8.9   

Fiscal Year

     17  
   8.10   

Seal

     17  
   8.11   

Transfer of Stock

     17  
   8.12   

Stock Transfer Agreements

     17  
   8.13   

Registered Stockholders

     17  
   8.14   

Signatures

     17  
   8.15   

Conflicts With Certificate of Incorporation

     17  

Article IX Amendments

     18  

 

-ii-


BYLAWS

OF

ASTRA SPACE, INC.

ARTICLE I

CORPORATE OFFICES

1.1 Principal Office. The Board of Directors shall fix the location of the principal executive offices of Astra Space, Inc. (the “Company”) at any place within or outside the State of Delaware.

1.2 Other Offices. The Board of Directors may at any time establish other offices at any place or places where the Company is qualified to do business.

ARTICLE II

MEETINGS OF STOCKHOLDERS

2.1 Place Of Meetings. Meetings of stockholders shall be held at any place, within or outside the State of Delaware, designated by the Board of Directors. In the absence of any such designation, stockholders’ meetings shall be held at the principal office of the Company.

2.2 Annual Meeting. The annual meeting of stockholders shall be held on such date, time and place, either within or outside the State of Delaware, as may be designated by the Board of Directors each year. At the meeting, directors shall be elected and any other proper business may be transacted.

2.3 Special Meeting. Except as provided by applicable law or in the certificate of incorporation, a special meeting of the stockholders may be called at any time by the Board of Directors, the Chairman of the Board, the Chief Executive Officer, the President or by one or more stockholders holding shares in the aggregate entitled to cast not less than ten percent (10%) of the votes at that meeting. If a special meeting is called by any person or persons other than the Board of Directors, the Chairman of the Board, the Chief Executive Officer or the President, the request shall be in writing, specifying the time of such meeting and the general nature of the business proposed to be transacted and shall be delivered personally or sent by certified mail or by electronic transmission to the Chairman of the Board, the Chief Executive Officer, the President, any Vice President or the Secretary of the Company. No business may be transacted at such special meeting otherwise than specified in such notice. The officer receiving the request shall cause notice to be promptly given to the stockholders entitled to vote, in accordance with the provisions of this Article II, that a meeting will be held at the time requested by the person or persons calling the meeting, not less than thirty five (35) nor more than sixty (60) days after the receipt of the request. Nothing contained in this Section 2.3 shall be construed as limiting, fixing or affecting the time when a meeting of stockholders called by action of the Board of Directors may be held.


2.4 Notice of Stockholders Meetings. All notices of meetings of stockholders shall be in writing and shall be given in accordance with Section 2.5 of these Bylaws not less than ten (10) nor more than sixty (60) days before the date of the meeting to each stockholder entitled to vote at such meeting. The notice shall specify the place (if any), date and hour of the meeting, the means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present and vote at such meeting and, in the case of a special meeting, the purpose or purposes for which the meeting is called.

2.5 Manner of Giving Notice; Affidavit of Notice. Written notice of any meeting of stockholders, if mailed, is given when deposited in the United States mail, postage prepaid, directed to the stockholder at the stockholder’s address as it appears on the records of the Company. Without limiting the manner by which notice otherwise may be given effectively to stockholders, any notice to stockholders may be given by electronic mail or other electronic transmission in the manner provided in Section 232 of the General Corporation Law of the State of Delaware (the “DGCL”). An affidavit of the secretary or an assistant secretary or of the transfer agent of the Company that the notice has been given shall, in the absence of fraud, be prima facie evidence of the facts stated therein.

2.6 Quorum. Except as provided by applicable law or in the certificate of incorporation, the holders of a majority of the shares of stock issued and outstanding and entitled to vote thereat, present in person or represented by proxy, shall constitute a quorum at all meetings of the stockholders for the transaction of business except as otherwise provided by applicable law or by the certificate of incorporation. If, however, such quorum is not present or represented at any meeting of the stockholders, either (a) the chairman of the meeting or (b) holders of a majority of the shares of stock entitled to vote who are present, in person or by proxy, shall have power to adjourn the meeting to another place (if any), date or time.

2.7 Adjourned Meeting; Notice. When a meeting is adjourned to another place (if any), date or time, unless these Bylaws otherwise require, notice need not be given of the adjourned meeting if the time and place (if any) thereof and the means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present and vote at such adjourned meeting are announced at the meeting at which the adjournment is taken. At the adjourned meeting, the Company may transact any business that might have been transacted at the original meeting. If the adjournment is for more than thirty (30) days, or if after the adjournment a new record date is fixed for the adjourned meeting, notice of the place (if any), date and time of the adjourned meeting and the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.

2.8 Organization; Conduct of Business. The Chairman of the Board or, in his or her absence, the Chief Executive Officer or, in his or her absence, the President or, in his or her absence, such person as the Board of Directors may have designated or, in the absence of such a person, such person as may be chosen by the holders of a majority of the shares entitled to vote who are present, in person or by proxy, shall call to order any meeting of the stockholders and act as chairman of the meeting. In the absence of the Secretary of the Company, the secretary of the meeting shall be such person as the chairman of the meeting appoints. The chairman of any meeting of stockholders shall determine the order of business and the procedure at the meeting, including the manner of voting and the conduct of business. The date and time of opening and closing of the polls for each matter upon which the stockholders will vote at the meeting shall be announced at the meeting.

 

-2-


2.9 Voting. The stockholders entitled to vote at any meeting of stockholders shall be determined in accordance with the provisions of Article II of these Bylaws, subject to the provisions of Sections 217 and 218 of the DGCL (relating to voting rights of fiduciaries, pledgors and joint owners of stock and to voting trusts and other voting agreements). Except as may be required by law or otherwise provided in the certificate of incorporation, (a) each stockholder shall be entitled to one vote for each share of capital stock held by such stockholder, (b) all elections shall be determined by a plurality of the votes cast, and (c) all other matters shall be determined by a majority of the votes cast affirmatively or negatively.

2.10 Waiver of Notice. Whenever notice is required to be given under any provision of the DGCL or of the certificate of incorporation or these Bylaws, a written waiver thereof, signed by the person entitled to notice, or waiver by electronic mail or other electronic transmission by such person, whether before or after the time stated therein, shall be deemed equivalent to notice. Attendance of a person at a meeting shall constitute a waiver of notice of such meeting, except when the person attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the stockholders need be specified in any written waiver of notice, or any waiver of notice by electronic transmission, unless so required by the certificate of incorporation or these Bylaws.

2.11 Stockholder Action by Written Consent Without a Meeting.

(a) Unless otherwise provided in the certificate of incorporation, any action required to be taken at any annual or special meeting of stockholders of the Company, or any action that may be taken at any annual or special meeting of such stockholders, may be taken without a meeting, without prior notice and without a vote if a consent in writing, setting forth the action so taken, is (i) signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted, and (ii) delivered to the Company in accordance with Section 228 of the DGCL.

(b) Every written consent shall bear the date of signature of each stockholder who signs the consent, and no written consent shall be effective to take the corporate action referred to therein unless, within sixty (60) days of the date the earliest dated consent is delivered to the Company, a written consent or consents signed by a sufficient number of holders to take action are delivered to the Company in the manner prescribed in this Section 2.11. An electronic mail or other electronic transmission consenting to an action to be taken and transmitted by a stockholder or proxyholder, or by a person or persons authorized to act for a stockholder or proxyholder, shall be deemed to be written, signed and dated for purposes of this Section 2.11 to the extent permitted by, and shall be delivered in accordance with, Section 228 of the DGCL.

 

-3-


(c) Any copy, facsimile or other reliable reproduction of a consent in writing may be substituted or used in lieu of the original writing for any and all purposes for which the original writing could be used, provided that such copy, facsimile or other reproduction shall be a complete reproduction of the entire original writing.

(d) Prompt notice of the taking of the corporate action without a meeting by less than unanimous written consent shall be given to those stockholders who have not consented in writing (including by electronic mail or other electronic transmission as permitted by law). If the action which is consented to is such as would have required the filing of a certificate under any Section of the DGCL if such action had been voted on by stockholders at a meeting thereof, the certificate filed under such Section shall state, in lieu of any statement required by such Section concerning any vote of stockholders, that written notice and written consent have been given as provided in Section 228 of the DGCL.

2.12 Record Date for Stockholder Notice, Voting and Consents.

(a) In order that the Company may determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof, or entitled to take action by written consent without a meeting, or entitled to receive payment of any dividend or other distribution or allotment of any rights, or entitled to exercise any rights in respect of any change, conversion or exchange of stock, or for the purpose of any other lawful action, the Board of Directors may fix, in advance, a record date, which shall not be less than ten (10) nor more than sixty (60) days before the date of such meeting, nor more than sixty (60) days prior to any other action. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting, if such adjournment is for thirty (30) days or less, provided that the Board of Directors may fix a new record date for the adjourned meeting.

(b) If the Board of Directors does not so fix a record date:

(i) The record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on which notice is given or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held.

(ii) The record date for determining stockholders entitled to consent to corporate action in writing without a meeting, when no prior action by the Board of Directors is necessary, shall be the day on which the first written consent is delivered to the Company.

(iii) The record date for determining stockholders for any other purpose shall be at the close of business on the day on which the Board of Directors adopts the resolution relating thereto.

2.13 Proxies. Each stockholder entitled to vote at a meeting of stockholders or to take action by written consent without a meeting may authorize another person or persons to act for such stockholder by an instrument in writing or by an electronic transmission permitted by law filed with the secretary of the Company, but no such proxy shall be voted or acted upon after three (3) years from its date, unless the proxy provides for a longer period. A proxy shall be deemed signed if the stockholder’s name is placed on the proxy (whether by manual signature, typewriting, electronic transmission or otherwise) by the stockholder or the stockholder’s attorney-in-fact. The revocability of a proxy that states on its face that it is irrevocable shall be governed by the provisions of Section 212 of the DGCL.

 

-4-


2.14 Meetings by Telephone or Similar Communications. If authorized by the Board of Directors, in its sole discretion, and subject to such guidelines and procedures as the Board of Directors may adopt, stockholders and proxyholders not physically present at a meeting of stockholders may, by means of remote communication:

(a) participate in a meeting of stockholders; and

(b) be deemed present in person and vote at a meeting of stockholders, whether such meeting is to be held at a designated place or solely by means of remote communication, provided that (i) the Company shall implement reasonable measures to verify that each person deemed present and permitted to vote at the meeting by means of remote communication is a stockholder or proxyholder, (ii) the Company shall implement reasonable measures to provide such stockholders and proxyholders a reasonable opportunity to participate in the meeting and to vote on matters submitted to the stockholders, including an opportunity to read or hear the proceedings of the meeting substantially concurrently with such proceedings, and (iii) if any stockholder or proxyholder votes or takes other action at the meeting by means of remote communication, a record of such vote or other action shall be maintained by the Company.

2.15 Ratification of Acts of Directors and Officers. Except as provided by applicable law or in the certificate of incorporation, any transaction or contract or act of the Company or of the directors or the officers of the Company may be ratified by the affirmative vote of the holders of outstanding stock having not less than the minimum number of votes that would have been necessary to approve or authorize such transaction, contract or act at a meeting of stockholders at which all shares entitled to vote thereon were present and voted, or by the written consent of stockholders in lieu of a meeting in accordance with Section 2.11 of these Bylaws.

ARTICLE III

DIRECTORS

3.1 Powers. Subject to the provisions of the DGCL and any limitations in the certificate of incorporation or these Bylaws relating to action required to be approved by the stockholders, the business and affairs of the Company shall be managed and all corporate powers shall be exercised by or under the direction of the Board of Directors.

3.2 Number of Directors. Upon the adoption of these Bylaws, the initial number of directors constituting the entire Board of Directors shall be two (2). Thereafter, unless otherwise provided in the certificate of incorporation, this number may be changed by a resolution of the Board of Directors or of the stockholders, subject to Section 3.4 of these Bylaws. No reduction of the authorized number of directors shall have the effect of removing any director before such director’s term of office expires.

 

-5-


3.3 Election, Qualification and Term of Office of Directors. Except as provided in Section 3.4 of these Bylaws, and unless otherwise provided in the certificate of incorporation, directors shall be elected at each annual meeting of stockholders to hold office until the next annual meeting. Directors need not be stockholders unless so required by the certificate of incorporation or these Bylaws. Each director, including a director elected to fill a vacancy, shall hold office until his or her successor is elected and qualified or until his or her earlier resignation or removal. Unless otherwise specified in the certificate of incorporation, elections of directors need not be by written ballot.

3.4 Resignation and Vacancies.

(a) Any director may resign at any time upon notice given in writing or by electronic transmission to the Board of Directors, the Chief Executive Officer, the President or the Secretary of the Company. When one or more directors so resigns and the resignation is effective at a future date, a majority of the directors then in office, including those who have so resigned, shall have the power to fill such vacancy or vacancies, the vote thereon to take effect when such resignation or resignations shall become effective, and each director so chosen shall hold office as provided in this Section in the filling of other vacancies.

(b) Unless otherwise provided in the certificate of incorporation or these Bylaws:

(i) Vacancies and newly created directorships resulting from any increase in the authorized number of directors elected by all of the stockholders having the right to vote as a single class may be filled by a majority of the directors then in office, although less than a quorum, or by a sole remaining director.

(ii) Whenever the holders of any class of stock or series thereof are entitled to elect one or more directors by the provisions of the certificate of incorporation, vacancies and newly created directorships of such class or series may be filled by a majority of the directors elected by such class or series thereof then in office, or by a sole remaining director so elected.

(c) If at any time, by reason of death or resignation or other cause, the Company should have no directors in office, any officer or any stockholder or an executor, administrator, trustee or guardian of a stockholder, or other fiduciary entrusted with like responsibility for the person or estate of a stockholder, may call a special meeting of stockholders in accordance with the provisions of the certificate of incorporation or these Bylaws, or may apply to the Court of Chancery for a decree summarily ordering an election as provided in Section 211 of the DGCL.

(d) If, at the time of filling any vacancy or any newly created directorship, the directors then in office constitute less than a majority of the whole board (as constituted immediately prior to any such increase), then the Court of Chancery may, upon application of any stockholder or stockholders holding at least ten percent (10%) of the total number of the shares at the time outstanding having the right to vote for such directors, summarily order an election to be held to fill any such vacancies or newly created directorships, or to replace the directors chosen by the directors then in office as aforesaid, which election shall be governed by the provisions of Section 211 of the DGCL as far as applicable.

 

-6-


3.5 Place of Meetings; Meetings by Telephone. The Board of Directors of the Company may hold meetings, both regular and special, either within or outside the State of Delaware. Unless otherwise restricted by the certificate of incorporation or these Bylaws, members of the Board of Directors, or any committee designated by the Board of Directors, may participate in a meeting of the Board of Directors, or any committee, by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other, and such participation in a meeting shall constitute presence in person at the meeting.

3.6 Regular Meetings. Regular meetings of the Board of Directors may be held without notice at such time and at such place as shall from time to time be determined by the Board of Directors.

3.7 Special Meetings; Notice. Special meetings of the Board of Directors for any purpose or purposes may be called at any time by the Chairman of the Board, the Chief Executive Officer, the President, any Vice President, the Secretary or any two directors. Notice of the time and place of special meetings shall be delivered personally or by telephone to each director or sent by first-class mail or electronic transmission, charges prepaid, addressed to each director at that director’s address as it is shown on the records of the Company. If the notice is mailed, it shall be deposited in the United States mail at least four (4) days before the time of the holding of the meeting. If the notice is delivered personally or by electronic transmission or telephone, it shall be delivered at least twenty four (24) hours before the time of the holding of the meeting. Any oral notice given personally or by telephone may be communicated either to the director or to a person at the office of the director who the person giving the notice has reason to believe will promptly communicate it to the director. The notice need not specify the purpose of the meeting and need not specify the place of the meeting as long as the meeting is to be held at the principal executive office of the Company. Unless otherwise indicated in the notice thereof, any and all business may be transacted at a special meeting.

3.8 Quorum. A majority of the directors then in office, but in no event less than one-third (1/3) of the total number of authorized directors, shall constitute a quorum for the transaction of business, and the act of a majority of the directors present at any meeting at which there is a quorum shall be the act of the Board of Directors, except as may be otherwise specifically provided by applicable law or by the certificate of incorporation. If a quorum is not present at any meeting of the Board of Directors, the directors present at the meeting may adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum is present. A meeting at which a quorum is initially present may continue to transact business notwithstanding the withdrawal of directors as long as any action taken is approved by at least a majority of the required quorum for that meeting.

3.9 Waiver of Notice. Whenever notice is required to be given under any provision of the DGCL or of the certificate of incorporation or these Bylaws, a written waiver thereof, signed by the person entitled to notice, or waiver by electronic mail or other electronic transmission by such person, whether before or after the time stated therein, shall be deemed equivalent to notice. Attendance of a person at a meeting shall constitute a waiver of notice of such meeting, except when the person attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the directors, or members of a committee of directors, need be specified in any written waiver of notice unless so required by the certificate of incorporation or these Bylaws.

 

-7-


3.10 Board Action by Written Consent Without a Meeting. Unless otherwise restricted by the certificate of incorporation or these Bylaws, any action required or permitted to be taken at any meeting of the Board of Directors, or of any committee thereof, may be taken without a meeting if all members of the board or committee, as the case may be, consent thereto in writing or by electronic transmission, and the writing or writings or electronic transmission or transmissions are filed with the minutes of proceedings of the board or committee. Such filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in electronic form. Any copy, facsimile or other reliable reproduction of a consent in writing may be substituted or used in lieu of the original writing for any and all purposes for which the original writing could be used, provided that such copy, facsimile or other reproduction shall be a complete reproduction of the entire original writing.

3.11 Fees and Compensation of Directors. Unless otherwise restricted by the certificate of incorporation or these Bylaws, the Board of Directors shall have the authority to fix the compensation of directors. No such compensation shall preclude any director from serving the Company in any other capacity and receiving compensation therefor.

3.12 Removal of Directors. Unless otherwise restricted by applicable law, by the certificate of incorporation or by these Bylaws, any director or the entire Board of Directors may be removed, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of directors; provided, however, that if the stockholders of the Company are entitled to cumulative voting, if less than the entire Board of Directors is to be removed, no director may be removed without cause if the votes cast against such director’s removal would be sufficient to elect such director if then cumulatively voted at an election of the entire Board of Directors.

ARTICLE IV

COMMITTEES

4.1 Committees of Directors. The Board of Directors may designate one or more committees, each committee to consist of one or more of the directors of the Company. The Board of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee. In the absence or disqualification of a member of a committee, the member or members present at any meeting and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another member of the Board of Directors to act at the meeting in the place of any such absent or disqualified member. Any such committee, to the extent provided in the resolution of the Board of Directors, or in these Bylaws, shall have and may exercise all the powers and authority of the Board of Directors in the management of the business and affairs of the Company and may authorize the seal of the Company to be affixed to all papers which may require it; provided, however, that no such committee shall have the power or authority in reference to the following matters: (a) approving or adopting, or recommending to the stockholders, any action or matter expressly required by the DGCL to be submitted to stockholders for approval; or (b) adopting, amending or repealing any bylaw of the Company.

 

-8-


4.2 Committee Minutes. Each committee shall keep regular minutes of its meetings and report the same to the Board of Directors when required.

4.3 Meetings and Action of Committees. Meetings and actions of committees shall be governed by, and held and taken in accordance with, the provisions of Section 3.5 (place of meetings and meetings by telephone), Section 3.6 (regular meetings), Section 3.7 (special meetings and notice), Section 3.8 (quorum), Section 3.9 (waiver of notice) and Section 3.10 (action without a meeting) of these Bylaws, with such changes in the context of such provisions as are necessary to substitute the committee and its members for the Board of Directors and its members; provided, however, that the time of regular meetings of committees may be determined either by resolution of the Board of Directors or by resolution of the committee, that special meetings of committees may also be called by resolution of the Board of Directors and that notice of special meetings of committees shall also be given to all alternate members, who shall have the right to attend all meetings of the committee. The Board of Directors may adopt rules for the government of any committee not inconsistent with the provisions of these Bylaws.

ARTICLE V

OFFICERS

5.1 Officers. The Board of Directors shall appoint a Chief Executive Officer and a Secretary. The Company may also have, at the discretion of the Board of Directors, a Chairman of the Board, a President, a Chief Financial Officer, a Treasurer, one or more Vice Presidents, one or more Assistant Secretaries, and any such other officers as may be appointed in accordance with the provisions of Section 5.3 of these Bylaws. Any number of offices may be held by the same person.

5.2 Appointment of Officers. The officers of the Company, except such officers as may be appointed in accordance with the provisions of Sections 5.3 or 5.5 of these Bylaws, shall be appointed by the Board of Directors, and each shall serve at the pleasure of the Board, subject to the rights, if any, of an officer under any contract of employment.

5.3 Subordinate Officers. The Board of Directors may appoint, or empower the Chief Executive Officer or the President to appoint, such other officers and agents as the business of the Company may require, each of whom shall hold office for such period, have such authority and perform such duties as are provided in these Bylaws or as the Board of Directors may from time to time determine.

5.4 Removal and Resignation of Officers. Subject to the rights, if any, of an officer under any contract of employment, any officer may be removed, either with or without cause, by the Board of Directors or, except in the case of an officer chosen by the Board of Directors, by any officer upon whom the power of removal is conferred by the Board of Directors. Any officer may resign at any time by giving notice in writing or by electronic transmission to the Company. Any resignation shall take effect at the date of the receipt of that notice or at any later time specified in that notice, and unless otherwise specified in that notice, the acceptance of the resignation shall not be necessary to make it effective. Any resignation is without prejudice to the rights, if any, of the Company under any contract to which the officer is a party.

 

-9-


5.5 Vacancies in Offices. Any vacancy occurring in any office of the Company shall be filled in the manner prescribed by these Bylaws for regular appointment to that office.

5.6 Chairman of the Board. The Chairman of the Board, if such an officer be elected, shall, if present, preside at meetings of the Board of Directors and exercise and perform such other powers and duties as may from time to time be assigned by the Board of Directors or as may be prescribed by these Bylaws.

5.7 Chief Executive Officer. Subject to such powers, if any, as may be given by the Board of Directors to the Chairman of the Board, if any, the Chief Executive Officer of the Company shall, subject to the control of the Board of Directors, have general supervision, direction and control of the business and the officers of the Company. The Chief Executive Officer shall preside at all meetings of the stockholders and, in the absence or disability of the Chairman of the Board, at all meetings of the Board of Directors and shall have the general powers and duties of management usually vested in the office of Chief Executive Officer of a corporation and such other powers and duties as may be prescribed by the Board of Directors or these Bylaws.

5.8 President. Subject to such powers, if any, as may be given by the Board of Directors to the Chairman of the Board (if any) or the Chief Executive Officer (if any), the President shall, subject to the control of the Board of Directors, have general supervision, direction and control of the business and other officers of the Company. The President shall have the general powers and duties of management usually vested in the office of president of a corporation and such other powers and duties as may be prescribed by the Board of Directors or these Bylaws. In the absence or disability of the Chief Executive Officer, the President shall perform all the duties of the Chief Executive Officer and when so acting shall have all the powers of, and be subject to all the restrictions upon, the Chief Executive Officer.

5.9 Vice Presidents. In the absence or disability of the Chief Executive Officer and President, the Vice Presidents, if any, in order of their rank as fixed by the Board of Directors or, if not ranked, a Vice President designated by the Board of Directors, shall perform all the duties of the President and when so acting shall have all the powers of, and be subject to all the restrictions upon, the President. The Vice Presidents shall have such other powers and perform such other duties as from time to time may be prescribed for them respectively by the Board of Directors, these Bylaws, the Chief Executive Officer, President or the Chairman of the Board.

5.10 Secretary. The Secretary shall keep or cause to be kept, at the principal executive office of the Company or such other place as the Board of Directors may direct, a book of minutes of all meetings and actions of directors, committees of directors and stockholders. The minutes shall show the time and place of each meeting, the names of those present at directors’ meetings or committee meetings, the number of shares present or represented at stockholders’ meetings and the proceedings thereof. The Secretary shall keep, or cause to be kept, at the principal executive office of the Company or at the office of the Company’s transfer agent or registrar, as determined by resolution of the Board of Directors, a share register, or a duplicate share register, showing the names of all stockholders and their addresses, the number and classes of shares held by each, the number and date of certificates evidencing such shares and the number and date of cancellation of every certificate surrendered for cancellation. The Secretary shall give, or cause to be given, notice of all meetings of the stockholders and of the Board of Directors required to be given by law or by these Bylaws. The Secretary shall keep the seal of the Company, if one is adopted, in safe custody and shall have such other powers and perform such other duties as may be prescribed by the Board of Directors or by these Bylaws.

 

-10-


5.11 Chief Financial Officer. The Chief Financial Officer shall have the custody of the corporate funds and securities and shall keep and maintain, or cause to be kept and maintained, adequate and correct books and records of accounts of the properties and business transactions of the Company, including accounts of its assets, liabilities, receipts, disbursements, gains, losses, capital retained earnings and shares. The books of account shall at all reasonable times be open to inspection by any director. The Chief Financial Officer shall deposit all moneys and other valuables in the name and to the credit of the Company with such depositories as may be designated by the Board of Directors. The Chief Financial Officer shall disburse the funds of the Company as may be ordered by the Board of Directors, shall render to the Board of Directors, the Chief Executive Officer or the President, upon request, an account of all his or her transactions as Chief Financial Officer and of the financial condition of the Company, and shall have other powers and perform such other duties as may be prescribed by the Board of Directors or the Bylaws.

5.12 Assistant Secretary. The Assistant Secretary or, if there is more than one, the Assistant Secretaries in the order determined by the Board of Directors (or if there is no such determination, then in the order of their election) shall, in the absence or disability of the Secretary, perform the duties and exercise the powers of the Secretary and such other duties and powers as may be prescribed by the Board of Directors or these Bylaws.

5.13 Treasurer. The Treasurer (if one is appointed) shall have such duties as may be specified by the Chief Financial Officer to assist the Chief Financial Officer in the performance of his or her duties and shall perform such other duties and have other powers as may from time to time be prescribed by the Board of Directors or the Chief Executive Officer.

5.14 Representation of Shares of Other Corporations. The Chairman of the Board, the Chief Executive Officer, the President, any Vice President, the Chief Financial Officer, the Secretary or Assistant Secretary of this Company, or any other person authorized by the Board of Directors or the Chief Executive Officer, the President, the Chief Financial Officer or a Vice President, is authorized to vote, represent and exercise on behalf of this Company all rights incident to any and all shares of any other corporation standing in the name of this Company. The authority granted herein may be exercised either by such person directly or by any other person authorized to do so by proxy or power of attorney duly executed by the person having such authority.

5.15 Authority and Duties of Officers. In addition to the foregoing authority and duties, all officers of the Company shall respectively have such authority and perform such duties in the management of the business of the Company as may be designated from time to time by the Board of Directors.

 

-11-


ARTICLE VI

INDEMNIFICATION OF DIRECTORS, OFFICERS,

EMPLOYEES AND OTHER AGENTS

6.1 Right to Indemnification. To the fullest extent permitted by applicable law, as the same exists or may hereafter be amended, the Company shall indemnify and hold harmless each person who was or is made a party or is threatened to be made a party to or is otherwise involved in any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (hereinafter a “proceeding”), by reason of the fact that he or she is or was a director or officer of the Company or, while a director or officer of the Company, is or was serving at the request of the Company as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, other enterprise or nonprofit entity, including service with respect to an employee benefit plan (hereinafter an “Indemnitee”), whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee or agent, or in any other capacity while serving as a director, officer, employee or agent, against all liability and loss suffered and expenses (including, without limitation, attorneys’ fees, judgments, fines, ERISA excise taxes and penalties and amounts paid in settlement) reasonably incurred by such Indemnitee in connection with such proceeding; provided, however, that, except as provided in Section 6.3 with respect to proceedings to enforce rights to indemnification, the Company shall indemnify an Indemnitee in connection with a proceeding (or part thereof) initiated by such Indemnitee only if such proceeding (or part thereof) was authorized by the Board of Directors.

6.2 Right to Advancement of Expenses. In addition to the right to indemnification conferred in Section 6.1, an Indemnitee shall also have the right to be paid by the Company, to the fullest extent not prohibited by applicable law, the expenses (including, without limitation, attorneys’ fees) incurred in defending or otherwise participating in any such proceeding in advance of its final disposition (hereinafter an “advancement of expenses”); provided, however, that, if the DGCL requires, an advancement of expenses incurred by an Indemnitee in his or her capacity as a director or officer of the Company (and not in any other capacity in which service was or is rendered by such Indemnitee, including, without limitation, service to an employee benefit plan) shall be made only upon the Company’s receipt of an undertaking (hereinafter an “undertaking”), by or on behalf of such Indemnitee, to repay all amounts so advanced if it shall ultimately be determined that such Indemnitee is not entitled to be indemnified under this Article VI or otherwise.

6.3 Right of Indemnitee to Bring Suit. If a claim under Section 6.1 or Section 6.2 is not paid in full by the Company within 60 days after a written claim therefor has been received by the Company, except in the case of a claim for an advancement of expenses, in which case the applicable period shall be 20 days, the Indemnitee may, at any time thereafter, bring suit against the Company to recover the unpaid amount of the claim. If successful in whole or in part in any such suit, or in a suit brought by the Company to recover an advancement of expenses pursuant to the terms of an undertaking, the Indemnitee shall also be entitled to be paid the expense of prosecuting or defending such suit. In (a) any suit brought by the Indemnitee to enforce a right to indemnification hereunder (but not in a suit brought by an Indemnitee to enforce a right to an advancement of expenses) it shall be a defense that, and (b) in any suit brought by the Company to recover an advancement of expenses pursuant to the terms of an undertaking, the Company shall be entitled to recover such expenses upon a final judicial decision from which there is no further

 

-12-


right to appeal (hereinafter a “final adjudication”) that, the Indemnitee has not met any applicable standard for indemnification set forth in the DGCL. Neither the failure of the Company (including its directors who are not parties to such action, a committee of such directors, independent legal counsel, or its stockholders) to have made a determination prior to the commencement of such suit that indemnification of the Indemnitee is proper in the circumstances because the Indemnitee has met the applicable standard of conduct set forth in the DGCL, nor an actual determination by the Company (including a determination by its directors who are not parties to such action, a committee of such directors, independent legal counsel, or its stockholders) that the Indemnitee has not met such applicable standard of conduct, shall create a presumption that the Indemnitee has not met the applicable standard of conduct or, in the case of such a suit brought by the Indemnitee, shall be a defense to such suit. In any suit brought by the Indemnitee to enforce a right to indemnification or to an advancement of expenses hereunder, or by the Company to recover an advancement of expenses pursuant to the terms of an undertaking, the burden of proving that the Indemnitee is not entitled to be indemnified, or to such advancement of expenses, under this Article VI or otherwise shall be on the Company.

6.4 Non-Exclusivity of Rights. The rights provided to any Indemnitee pursuant to this Article VI shall not be exclusive of any other right, which such Indemnitee may have or hereafter acquire under applicable law, the certificate of incorporation, these Bylaws, an agreement, a vote of stockholders or disinterested directors, or otherwise.

6.5 Insurance. The Company may maintain insurance, at its expense, to protect itself and/or any director, officer, employee or agent of the Company or another corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss, whether or not the Company would have the power to indemnify such person against such expense, liability or loss under the DGCL.

6.6 Indemnification of Other Persons. This Article VI shall not limit the right of the Company to the extent and in the manner authorized or permitted by law to indemnify and to advance expenses to persons other than Indemnitees. Without limiting the foregoing, the Company may, to the extent authorized from time to time by the Board of Directors, grant rights to indemnification and to the advancement of expenses to any employee or agent of the Company and to any other person who is or was serving at the request of the Company as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust or other enterprise, including service with respect to an employee benefit plan, to the fullest extent of the provisions of this Article VI with respect to the indemnification and advancement of expenses of Indemnitees under this Article VI.

6.7 Amendments. Any repeal or amendment of this Article VI by the Board of Directors or the stockholders of the Company or by changes in applicable law, or the adoption of any other provision of these Bylaws inconsistent with this Article VI, will, to the extent permitted by applicable law, be prospective only (except to the extent such amendment or change in applicable law permits the Company to provide broader indemnification rights to Indemnitees on a retroactive basis than permitted prior thereto), and will not in any way diminish or adversely affect any right or protection existing hereunder in respect of any act or omission occurring prior to such repeal or amendment or adoption of such inconsistent provision; provided however, that amendments or repeals of this Article VI shall require the affirmative vote of the stockholders holding at least 66.7% of the voting power of all outstanding shares of capital stock of the Company.

 

-13-


6.8 Certain Definitions. For purposes of this Article VI, (a) references to “other enterprise” shall include any employee benefit plan; (b) references to “fines” shall include any excise taxes assessed on a person with respect to an employee benefit plan; (c) references to “serving at the request of the Company” shall include any service that imposes duties on, or involves services by, a person with respect to any employee benefit plan, its participants, or beneficiaries; and (d) a person who acted in good faith and in a manner such person reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner “not opposed to the best interest of the Company” for purposes of Section 145 of the DGCL.

6.9 Contract Rights. The rights provided to Indemnitees pursuant to this Article VI shall be contract rights and such rights shall continue as to an Indemnitee who has ceased to be a director, officer, agent or employee and shall inure to the benefit of the Indemnitee’s heirs, executors and administrators.

6.10 Severability. If any provision or provisions of this Article VI shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a) the validity, legality and enforceability of the remaining provisions of this Article VI shall not in any way be affected or impaired thereby; and (b) to the fullest extent possible, the provisions of this Article VI (including, without limitation, each such portion of this Article VI containing any such provision held to be invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested by the provision held invalid, illegal or unenforceable.

ARTICLE VII

RECORDS AND REPORTS

7.1 Maintenance and Inspection of Records.

(a) The Company shall, either at its principal executive offices or at such place or places as designated by the Board of Directors, keep a record of its stockholders listing their names and addresses and the number and class of shares held by each stockholder, a copy of these Bylaws as amended to date, accounting books and other records.

(b) Any stockholder of record, in person or by attorney or other agent, shall, upon written demand under oath stating the purpose thereof, have the right during the usual hours for business to inspect for any proper purpose the Company’s stock ledger, a list of its stockholders and its other books and records and to make copies or extracts therefrom. A proper purpose shall mean a purpose reasonably related to such person’s interest as a stockholder. In every instance where an attorney or other agent is the person who seeks the right to inspection, the demand under oath shall be accompanied by a power of attorney or such other writing that authorizes the attorney or other agent to so act on behalf of the stockholder. The demand under oath shall be directed to the Company at its registered office in Delaware or at its principal place of business.

 

-14-


(c) A complete list of stockholders entitled to vote at any meeting of stockholders, arranged in alphabetical order for each class and series of stock and showing the address of each such stockholder and the number of shares registered in each such stockholder’s name, shall be open to the examination of any such stockholder for a period of at least ten (10) days prior to the meeting in the manner provided by law. The stock list shall also be open to the examination of any stockholder during the whole time of the meeting as provided by law. This list shall presumptively determine the identity of the stockholders entitled to vote at the meeting and the number of shares held by each of them.

(d) The application and requirements of Section 1501 of the California Corporations Code, to the extent applicable, are hereby expressly waived to the fullest extent permitted thereunder.

7.2 Inspection by Directors. Any director shall have the right to examine the Company’s stock ledger, a list of its stockholders and its other books and records for a purpose reasonably related to his or her position as a director. The Court of Chancery is hereby vested with the exclusive jurisdiction to determine whether a director is entitled to the inspection sought. The Court may summarily order the Company to permit the director to inspect any and all books and records, the stock ledger and the stock list and to make copies or extracts therefrom. The Court may, in its discretion, prescribe any limitations or conditions with reference to the inspection or award such other and further relief as the Court may deem just and proper.

ARTICLE VIII

GENERAL MATTERS

8.1 Checks. From time to time, the Board of Directors shall determine by resolution which person or persons may sign or endorse all checks, drafts other orders for payment of money, notes or other evidences of indebtedness that are issued in the name of or payable to the Company, and only the persons so authorized shall sign or endorse those instruments.

8.2 Deposits. The funds of the Company may be deposited or invested in such bank account, in such investments or with such other depositories as determined by the Board of Directors.

8.3 Execution of Corporate Contracts and Instruments. The Board of Directors, except as otherwise provided by applicable law, the certificate of incorporation or in these Bylaws, may authorize any officers or agents to enter into any contract or execute any instrument in the name of and on behalf of the Company, and such authority may be general or confined to specific instances. Unless so authorized or ratified by the Board of Directors or within the agency power of an officer, no officer, agent or employee shall have any power or authority to bind the Company by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount.

8.4 Stock Certificates; Partly Paid Shares.

(a) The shares of the Company shall not be represented by certificates, provided that the Board of Directors of the Company may provide by resolution or resolutions that some or all of any or all classes or series of its stock shall be certificated shares. Every holder of stock represented by certificates and upon request every holder of uncertified shares shall be entitled to have a certificate signed by, or in the name of the Company by (i) the Chairman of the Board, the

 

-15-


Chief Executive Officer, the President or a Vice President, and (ii) the Treasurer or an Assistant Treasurer, or the Secretary or an Assistant Secretary of the Company, representing the number of shares registered in certificate form. Any or all of the signatures on the certificate may be by DocuSign. In case any officer, transfer agent or registrar who has signed or whose DocuSign signature has been placed upon a certificate has ceased to be such officer, transfer agent or registrar before such certificate is issued, it may be issued by the Company with the same effect as if he or she were such officer, transfer agent or registrar at the date of issue.

(b) The Company may issue the whole or any part of its shares as partly paid and subject to call for the remainder of the consideration to be paid therefor. Upon the face or back of each stock certificate issued to represent any such partly paid shares, or upon the books and records of the Company in the case of uncertificated partly paid shares, the total amount of the consideration to be paid therefor and the amount paid thereon shall be stated. Upon the declaration of any dividend on fully paid shares, the Company shall declare a dividend upon partly paid shares of the same class, but only upon the basis of the percentage of the consideration actually paid thereon.

8.5 Special Designation on Certificates. If the Company is authorized to issue more than one class of stock or more than one series of any class, the powers, designations, preferences and relative, participating, optional or other special rights of each class of stock or series thereof, and the qualifications, limitations or restrictions of such preferences and/or rights, shall be set forth in full or summarized on the face or back of the certificate if a certificate has been issued to represent such class or series of stock; provided, however, that, except as otherwise provided in Section 202 of the DGCL, in lieu of the foregoing requirements there may be set forth on the face or back of any such certificate that the Company has issued to represent such class or series of stock a statement that the Company will furnish without charge to each stockholder who so requests the powers, designations, preferences and relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights.

8.6 Lost Certificates. Except as provided in this Section 8.6, no new certificates for shares shall be issued to replace a previously issued certificate unless the latter is surrendered to the Company and cancelled at the same time. The Company may issue a new certificate of stock or uncertificated shares in the place of any certificate previously issued by it that is alleged to have been lost, stolen or destroyed and may require the owner of the lost, stolen or destroyed certificate, or the owner’s legal representative, to make an affidavit stating that the certificate has been lost, stolen or destroyed and/or to give the Company a bond sufficient to indemnify the Company against any claim that may be made against it on account of the alleged loss, theft or destruction of any such certificate or the issuance of such new certificate or uncertificated shares.

8.7 Construction; Definitions. Unless the context requires otherwise, the general provisions, rules of construction and definitions in the DGCL shall govern the construction of these Bylaws. Without limiting the generality of this provision, the singular number includes the plural, the plural number includes the singular and the term “person” includes both a corporation and a natural person.

 

-16-


8.8 Dividends. Subject to any restrictions contained in the DGCL or the certificate of incorporation, the Board of Directors may declare and pay dividends upon the shares of its capital stock. Dividends may be paid in cash, in property or in shares of the Company’s capital stock. The Board of Directors may set apart, out of any of the funds of the Company available for dividends, a reserve or reserves for any proper purpose and may abolish any such reserve. Such purposes shall include but not be limited to equalizing dividends, repairing or maintaining any property of the Company and meeting contingencies.

8.9 Fiscal Year. The fiscal year of the Company shall be fixed by resolution of the Board of Directors and may be changed by the Board of Directors.

8.10 Seal. The Company may adopt a corporate seal, which may be altered by the Board of Directors, and may use the same by causing it or a facsimile thereof to be impressed or affixed or in any other manner reproduced.

8.11 Transfer of Stock. Upon surrender to the Company or the transfer agent of the Company of a certificate for shares duly endorsed or accompanied by proper evidence of succession, assignation or authority to transfer, it shall be the duty of the Company to issue a new certificate to the person entitled thereto, cancel the old certificate and record the transaction in its books.

8.12 Stock Transfer Agreements. The Company shall have power to enter into and perform any agreement with any number of stockholders of any one or more classes or series of stock of the Company to restrict the transfer of shares of stock of the Company of any one or more classes or series owned by such stockholders in any manner not prohibited by the DGCL.

8.13 Registered Stockholders. The Company shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares to receive dividends and to vote as such owner, shall be entitled to hold liable for calls and assessments the person registered on its books as the owner of shares, and shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of another person, whether or not it shall have express or other notice thereof, except as otherwise provided by applicable law.

8.14 Signatures. In addition to the provisions for use of DocuSign signatures elsewhere specifically authorized in these Bylaws, DocuSign signatures of any officer or officers of the Company may be used whenever and as authorized by the Board of Directors or a committee thereof.

8.15 Conflicts With Certificate of Incorporation. In the event of any conflict between the provisions of the Company’s certificate of incorporation and these Bylaws, the provisions of the certificate of incorporation shall govern.

 

-17-


ARTICLE IX

AMENDMENTS

These Bylaws may be adopted, amended or repealed by the stockholders or, to the extent such power is conferred on the Board of Directors in the Company’s certificate of incorporation, by the Board of Directors. The fact that such power has been so conferred upon the Board of Directors shall not divest the stockholders of the power, nor limit their power, to adopt, amend or repeal these Bylaws.

*  *  *

 

-18-


CERTIFICATE OF SECRETARY

The undersigned hereby certifies that the undersigned is the duly elected, qualified, and acting Secretary or Assistant Secretary of Astra Space, Inc., a Delaware corporation, and that the foregoing Bylaws were adopted as the Bylaws of the Company on July 18, 2024, by the person appointed in the certificate of incorporation to act as the Incorporator.

Executed on July 18, 2024.

 

/s/ Matthew Sant
Matthew Sant, Corporate Secretary

EXHIBIT 10.1

OMNIBUS TERMINATION AGREEMENT

This OMNIBUS TERMINATION AGREEMENT (this “Termination Agreement”) is effective as of July 18, 2024 (the “Effective Date”) by and between (i) Astra Space, Inc. (the “Company”) and each of its subsidiaries: Astra Space Operations, LLC (“ASO”), Apollo Fusion, LLC (“AF”), Indigo Space, LLC (“Indigo”), Astra Space Platform Holdings LLC (“Platform Holdings”), Astra Space Platform Services LLC (“Platform Services”), Astra Earth Operations LLC (“Earth Operations”), Astra Spacecraft Engines, Inc. (“Spacecraft”) and Astra Space Technologies Holdings, Inc. (“Space Technologies”) (each of ASO, AF, Indigo, Platform Holdings, Platform Services, Earth Operations, Spacecraft and Space Technologies, a “Subsidiary” and collectively, the “Subsidiaries”; and collectively with the Company, “Astra”); (ii) GLAS Americas LLC, as the Collateral Agent (“GLAS” or the “Collateral Agent”) and JMCM Holdings, LLC (“JMCM”), SherpaVentures Fund II, LP (“SherpaVentures”), Adam P. London (“London”), Chris C. Kemp, Trustee of the Chris Kemp Living Trustee, dated February 10, 2021 (“Kemp”), MH Orbit LLC (“MH Orbit”), RBH Ventures Astra SPV, LLC (“RBH”), Astera Institute (“Astera”), ERAS Capital, LLC (“ERAS”), Ulrich Gall (“Gall”), Richard Delmas Breezy Wynn (“Breezy”), and Chenel Capital Partners LLC (“Chenel”, together with JMCM, SherpaVentures, London, Kemp, MH Orbit, RBH, Astera, ERAS, Gall, and Breezy each a “Noteholder,” and collectively, the “Noteholders” and together with Astra and the Collateral Agent, the “Parties” and each, a “Party”).

RECITALS

 

  A.

Astra and the Noteholders previously entered into that certain Securities Purchase Agreement, dated as of August 4, 2023, as amended or modified by, inter alia, that certain Reaffirmation Agreement and Omnibus Amendment Agreement, dated as of November 6, 2023, that certain Omnibus Amendment No. 3 Agreement on November 21, 2023 (“Omnibus Amendment No. 3”), that certain Amendment to Securities Purchase Agreement, dated as of January 19, 2024, that certain Amendment to Senior Secured Convertible Notes, dated as of January 31, 2024, that certain Second Amendment to Securities Purchase Agreement and Second Amendment to Senior Secured Convertible Notes, dated as of February 26, 2024, that certain Limited Waiver and Consent to Senior Secured Convertible Notes and Common Stock Purchase Warrant and Reaffirmation of Transaction Documents, dated as of March 7, 2024, that certain Third Amendment to Securities Purchase Agreement and Third Amendment to Senior Secured Convertible Notes, dated as of April 10, 2014, that certain Fourth Amendment to Senior Secured Convertible Notes, dated as of April 30, 2024 and that certain Fifth Amendment to Senior Secured Convertible Notes, dated as of May 31, 2024 (as so amended and modified, the “Purchase Agreement”; capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Purchase Agreement.), pursuant to which, among other things, Astra issued senior secured convertible notes (each a “Note,” and collectively, the “Notes”) to the Noteholders.

 

  B.

To secure the Notes, Astra has granted a security interest or pledged certain assets (collectively, the “Collateral”) to the Collateral Agent (the “Pledge”).

 

  C.

Each of the Company, the Subsidiaries and the Collateral Agent is a party to one or both of the security agreements listed in items 1 and 2 on Exhibit A attached hereto (collectively, the “Security Agreements”) and the guaranty agreement listed in item 3 on Exhibit A attached hereto (the “Guaranty Agreement” and, together with the Security Agreements and the Purchase Agreement, the “Payoff Transaction Documents”), which Security Agreements evidence the Pledge.


  D.

The Company has entered into an Agreement and Plan of Merger (as amended from time to time, the “Merger Agreement”), by and between the Company, Apogee Parent Inc. (“Parent”), and Apogee Merger Sub Inc., a wholly owned Subsidiary of Parent (“Merger Sub”), pursuant to which (among other things) the Merger Sub will merge with and into the Company, with the Company surviving such merger as a wholly owned subsidiary of Parent (the “Merger”).

 

  E.

On July 18, 2024, Merger Sub and Astra filed a Certificate of Merger with the Delaware Secretary of State to be effective as of 7:00 A.M. eastern time on the Effective Date (the “Effective Time”).

 

  F.

At the Effective Time, the Merger was consummated.

 

  G.

In connection with the consummation of the Merger, and pursuant to, and in accordance with, the terms of that certain Noteholder Conversion Agreement, dated as of March 7, 2024, among Parent, Merger Sub and the Noteholders, effective as of the Effective Time, the outstanding principal (including capitalized PIK Interest) of, and accrued and unpaid interest on, the Notes were automatically converted into shares of Series A preferred stock, par value $0.0001 per share, of Parent and the Notes were deemed paid in full and cancelled (the “Conversion”).

 

  H.

The Company has further advised the Collateral Agent and the Noteholders that substantially simultaneously with the Effective Time and in conjunction with the Conversion, it intends to (i) terminate any ability of the Company to authorize the issuance and offering of additional Notes under the Purchase Agreement, through the termination of the Purchase Agreement hereunder, and (ii) pay all other monetary obligations of Astra under the Purchase Agreement and the other Transaction Documents that have accrued or otherwise arisen on or before the Effective Date, including amounts payable pursuant to any indemnity, expense reimbursement or prepayment provisions, in each case, other than the Continuing Obligations (as defined below).

 

  I.

Astra and the Noteholders have agreed to terminate the Payoff Transaction Documents and the security interests created by the Security Agreements and to further evidence the release of any and all rights that the Collateral Agent may have to the Collateral, and the Noteholders have agreed to direct the Collateral Agent to return to the Company all of the Collateral in its possession as more fully described and provided below.

AGREEMENT

NOW, THEREFORE, in consideration of the promises made herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, hereby agree as follows:

1.  Recitals Incorporated. The above recitals are acknowledged by Astra and the Noteholders to be true and correct.

2.  Termination of the Payoff Transaction Documents.

(a)  As of the Specified Time (as defined Section 5 hereof), the Payoff Transaction Documents and all rights and obligations of the Parties under or arising out of the Payoff Transaction Documents (other than contingent indemnities and any Continuing Obligations (as defined below)) are hereby terminated, extinguished cancelled and in the case of the security interests in favor of the Collateral Agent under the Security Agreements, released in all respects and shall be of no force or effect.


(b)  Nothing herein shall be deemed a release or termination of Astra’s obligations to the Collateral Agent or any Noteholder under or in respect of the Purchase Agreement or any other Transaction Document to the extent that such obligations are expressly stated to survive the payment of the Total Payoff Amount including, without limitation, any contingent indemnification obligations for which no claim has been asserted (collectively, the “Continuing Obligations”).

3.  Direction to the Collateral Agent. The Noteholders hereby irrevocably direct the Collateral Agent to:

 

  (a)

on the Effective Date, execute and deliver this Termination Agreement.

 

  (b)

subject to the occurrence of the Specified Time, deliver to the Company within five (5) Business Days following such Specified Time (or such later period as mutually agreed between the Parties) the possessory Collateral currently in the possession of the Collateral Agent and identified on the attached Exhibit B to the following address:

c/o Katheryn Gettman

Cozen O’Connor

33 South 6th Street, Suite 3800

Minneapolis, MN 55402

 

  (c)

contemporaneously with the Specified Time (as defined below) or as soon thereafter as practicable, execute and deliver the releases of the security interest in Astra’s intellectual property in the forms attached as Exhibit C.

 

  (d)

contemporaneously with the Specified Time (as defined below) or as soon thereafter as practicable, execute and deliver terminations of the deposit account control agreements with Bank of America and Silicon Valley Bank in the applicable form attached as Exhibit D.

 

  (e)

contemporaneously with the Specified Time (as defined below) or as soon thereafter as practicable, file, or authorize its designee, including the Company, as the case may be, to file the UCC-3 termination statements attached as Exhibit E.

4.  Collateral Agent. From and after the Specified Time, the Collateral Agent shall have no further obligations under the Payoff Transaction Documents and no further rights in and to the Collateral. In connection with this Termination Agreement and the transactions contemplated hereby, the Collateral Agent shall be afforded all of the rights, privileges, protections, immunities and benefits afforded to it under the Security Agreement and the Payoff Transaction Documents, as if such rights, privileges, protections, immunities and benefits were fully set forth herein mutatis mutandis.

5.  Attorneys’ Fee. Upon the Effective Time, the Company shall have paid all fees, charges, expenses and disbursements of the Collateral Agent and the Noteholders in connection with the preparation, execution and delivery of this Termination Agreement and release of the security interests to those persons and in the amount identified on Schedule II hereto (the “Total Payoff Amount”). The time that the Total Payoff Amount shall have been received by the persons identified on Schedule II hereto is referred to herein as the “Specified Time”.


6.  Acknowledgment of Note Balances. By the execution and delivery of this Termination Agreement:

(a)  The Company represents and warrants that the undersigned Noteholders hold 100% of the aggregate Principal Amount of the Notes; and

(b)  The Company and each Noteholder acknowledge and agree that, as of the Effective Date (i) the aggregate Principal Amount of each Note held by such Noteholder is set forth opposite the name of such Note of such Noteholder on Schedule I hereto under the column heading “Outstanding Principal Amount” and (ii) the aggregate amount of accrued and unpaid interest on such aggregate Principal Amount of such Note to but excluding the Effective Date is set forth on Schedule I hereto opposite such Note of such Noteholder under the column heading “Accrued and Unpaid Interest”.

(c)  The Company and each Noteholder acknowledge and agree that any release or termination provided by the Collateral Agent pursuant to or in connection with this Termination Agreement is provided without any representation, warranty or recourse by or to the Collateral Agent, and the Collateral Agent is not responsible for the content or sufficiency of any such documents; it being understood that all such documents have been prepared by or on behalf of Astra.

7.  Reinstatement. Astra agrees that if, at any time, the Merger is rescinded or all or any part of the Total Payoff Amount is or must be rescinded or returned by the Collateral Agent or any Noteholder for any reason whatsoever (including the insolvency, bankruptcy, reorganization or similar proceeding involving Astra), all Obligations and all other obligations under the Purchase Agreement and the other Transaction Documents or part thereof which were intended to be satisfied by any such payment or proceeds, to the extent that such payment is or must be rescinded or returned, shall be deemed to have continued in existence, notwithstanding such application by the Collateral Agent or such Noteholder, and the Purchase Agreement and the other Transaction Documents (but, for the avoidance of doubt, other than any Liens and security interests granted thereunder) shall continue to be effective or be reinstated, as the case may be, as to such Obligation and other obligations, all as though such application by the Collateral Agent or such Noteholder had not been made. Astra agrees to promptly correct, by means of all appropriate payments, any nonpayment, claim, refund or dishonor of any amounts, checks or other similar items which have been credited by the Collateral Agent or any Noteholder to any account of Astra with the Collateral Agent or any Noteholder in determining the Total Payoff Amount, together with any reasonable and documented out-of-pocket expenses or other reasonable and documented charges related thereto, and any clerical errors that may have been made in the calculation of the Total Payoff Amount. The provisions of this paragraph shall survive the termination of the Purchase Agreement and the other Transaction Documents.

8.  Release.

(a)  In addition, upon the Specified Time, Astra (on behalf of itself and its respective Subsidiaries and Affiliates), its successors-in-title, legal representatives and assignees and, to the extent the same is claimed by right of, through or under Astra, for its past, present and future employees, agents, representatives, officers, directors, shareholders, and trustees, does hereby and shall be deemed to have forever remised, released and discharged the Collateral Agent and Noteholders, their respective Affiliates, and any of the respective successors-in-title, legal representatives and assignees, past, present and future officers, directors, shareholders, trustees, agents, employees, consultants, experts, advisors, attorneys and other professionals and all other persons and entities to whom the Collateral Agent, any Noteholder, or any of their respective Affiliates would be liable if such persons or entities were found to be liable to Astra (collectively hereinafter the “Releasees”), from any and all manner of action and actions, cause and causes of action, claims, charges, demands, counterclaims, suits, debts, dues, sums of money, accounts,


reckonings, bonds, bills, specialties, covenants, contracts, controversies, damages, judgments, expenses, executions, liens, claims of liens, claims of costs, penalties, attorneys’ fees, or any other compensation, recovery or relief on account of any liability, obligation, demand or cause of action of whatever nature, whether in law, equity or otherwise (including without limitation those arising under 11 U.S.C. §§ 541-550 and interest or other carrying costs, penalties, legal, accounting and other professional fees and expenses, and incidental, consequential and punitive damages payable to third parties), whether known or unknown, fixed or contingent, joint and/or several, secured or unsecured, due or not due, primary or secondary, liquidated or unliquidated, contractual or tortious, direct, indirect, or derivative, asserted or unasserted, foreseen or unforeseen, suspected or unsuspected, now existing, heretofore existing or which may heretofore accrue against any of the Releasees, whether held in a personal or representative capacity, and which are based on any act, fact, event or omission or other matter, cause or thing (each, a “Claim”) occurring at or from any time prior to and including the date hereof in any way, directly or indirectly arising out of, connected with or relating to this Termination Agreement or any of the Transaction Documents, and the transactions contemplated thereby, and all other agreements, certificates, instruments and other documents and statements (whether written or oral) related to any of the foregoing).

(b)  Astra knowingly, voluntarily, intentionally and expressly grants such release on such terms set forth above notwithstanding that Astra may hereafter discover facts in addition to, or different from, those which that party now knows or believes to be true, and without regard to the subsequent discovery or existence of such different or additional facts, and, to the fullest extent permitted by applicable requirements of law, expressly waives and relinquishes all rights and benefits that Astra may have under any statute, procedural rule, common law principle, in equity or otherwise which would limit the effect of the foregoing release. Astra hereby agrees and acknowledges that the foregoing waiver was separately bargained for. This waiver is an essential term of this Termination Agreement, without which the Collateral Agent and the Noteholders would not have agreed for the Collateral Agent to execute this Termination Agreement. The release contained herein and the related provisions shall survive the termination of the Purchase Agreement and payment in full of the Obligations. Astra expressly acknowledges and agrees that the release in favor of the Releasees contained in this Termination Agreement shall not be construed as an admission of any wrongdoing, liability or culpability on the part of the Releasees, or as an admission by the Releasees of the existence of any Claims by Astra against the Releasees. Astra hereby agrees, represents, and warrants that it has not voluntarily, by operation of law or otherwise, assigned, conveyed, transferred or encumbered, either directly or indirectly, in whole or in part, any right to or interest in any of the Claims released hereby. Astra acknowledges and agrees that (a) it has been represented by independent legal counsel of its own choice throughout all of the negotiations that preceded the execution of this Termination Agreement and that it has executed this Termination Agreement after having received the advice of such independent legal counsel and (b) it and its counsel have had an adequate opportunity to make whatever investigation or inquiry they deem necessary or desirable in connection with the release of the Claims hereby. Astra acknowledges that the laws of many states provide substantially the following: “A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.” Astra acknowledges that such provisions are designed to protect a person from waiving Claims which such person does not know exist or may exist. As to each and every Claim released hereunder, Astra hereby represents that it has received the advice of legal counsel with regard to the releases contained herein, and having been so advised, agrees that it shall be deemed to waive any such provision (including, without limitation, Section 1542 of the Civil Code of California), if any, pertaining to general releases after having been advised by their legal counsel with respect thereto.


9.  Miscellaneous.

(a)  The Noteholders hereby direct the Collateral Agent to take, or cause to be taken, all actions and to do, or cause to be done, and to assist and cooperate with the other Parties in doing, at Astra’s sole cost and expense, all things commercially reasonably requested by Astra to consummate the transactions set forth in this Termination Agreement, including, but not limited to, the execution and delivery of such further documents (that are in form and substance reasonably satisfactory to the Collateral Agent, without representation, warranty or recourse) as may be prepared by Astra and reasonably requested to be executed to effectuate the purposes of this Termination Agreement.

(b)  The section headings in this Termination Agreement are for convenience only and are not to be considered in construing this Termination Agreement.

(c)  This Termination Agreement shall be binding upon and is solely for the benefit of the Parties. If any provision of this Termination Agreement is held invalid or unenforceable by any court of competent jurisdiction, then the other provisions of this Termination Agreement shall remain in full force and effect. This Termination Agreement may not be amended or modified except in a writing signed by all Parties.

(d)  This Termination Agreement shall be governed by and construed in accordance with the substantive laws of the State of Delaware. The provisions of Section 18 of the Purchase Agreement are incorporated herein mutatis mutandis.

(e)  This Termination Agreement constitutes the entire agreement by and between the Parties relating to the subject matter hereof. The terms and conditions of this Termination Agreement shall inure to the benefit of and be binding upon the respective heirs, legal representatives, successors and assigns of the Parties. Except as otherwise provided in this Termination Agreement, nothing in this Termination Agreement is intended to confer upon any Party, other than the Parties and their respective heirs, legal representatives, successors, and assigns, any rights, remedies, obligations, or liabilities under or by reason of this Termination Agreement.

(f)  This Termination Agreement may be signed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Any counterpart signature page delivered by facsimile, email (e.g., .pdf) or other electronic signature shall be deemed to be and have the same force and effect as an originally executed signature page.

[Remainder of Page Intentionally Left Blank; Signature Pages Follow]


IN WITNESS WHEREOF, the Parties have executed this Termination Agreement as of the Effective Date.

 

ASTRA SPACE, INC.
By:  

/s/ Axel Martinez

Name:   Axel Martinez
Title:   Chief Financial Officer
ASTRA SPACE OPERATIONS, LLC
By:  

/s/ Axel Martinez

Name:   Axel Martinez
Title:   Chief Financial Officer
APOLLO FUSION, LLC
By:  

/s/ Axel Martinez

Name:   Axel Martinez
Title:   Chief Financial Officer
INDIGO SPACE, LLC
By:  

/s/ Axel Martinez

Name:   Axel Martinez
Title:   Chief Financial Officer
ASTRA SPACE PLATFORM HOLDINGS LLC
By:  

/s/ Axel Martinez

Name:   Axel Martinez
Title:   Chief Financial Officer
ASTRA SPACE PLATFORM SERVICES LLC
By:  

/s/ Axel Martinez

Name:   Axel Martinez
Title:   Chief Financial Officer
ASTRA EARTH OPERATIONS LLC
By:  

/s/ Axel Martinez

Name:   Axel Martinez
Title:   Chief Financial Officer

{Signature Page to Omnibus Termination Agreement}


ASTRA SPACECRAFT ENGINES, INC.
By:  

/s/ Axel Martinez

Name:   Axel Martinez
Title:   Chief Financial Officer
ASTRA SPACE TECHNOLOGIES HOLDINGS, INC.
By:  

/s/ Axel Martinez

Name:   Axel Martinez
Title:   Chief Financial Officer

{Signature Page to Omnibus Termination Agreement}


GLAS AMERICAS LLC,

as Collateral Agent

By:  

/s/ Katie Fischer

Name:   Katie Fischer
Title:   Vice President

{Signature Page to Omnibus Termination Agreement}


SHERPAVENTURES FUND II, LP
By: SherpaVentures Fund II GP, LLC, Its General Partner
By:  

/s/ Brian Yee

Name:   Brian Yee
Title:   Partner

 

JMCM HOLDINGS LLC
By:  

/s/ Baldo Fodera

Name:   Baldo Fodera
Title:   Manager

/s/ Adam P. London

ADAM P. LONDON

 

CHRIS C. KEMP, TRUSTEE OF THE CHRIS KEMP LIVING TRUST, DATED FEBRUARY 10, 2021
By:  

/s/ Chris C. Kemp

Name:   Chris C. Kemp
Title:   Trustee
MH ORBIT LLC
By:  

/s/ Baldo Fodera

Name:   Baldo Fodera
Title:   Manager

{Signature Page to Omnibus Termination Agreement}


RBH VENTURES ASTRA SPV, LLC

By: RBH Ventures, Ltd., its Manager

By: Synchronicity Holdings, LLC, general partner of the Manager

By:  

/s/ Robert Bradley Hicks

Name:   Robert Bradley Hicks
Title:   Managing Member
ASTERA INSTITUTE
By:  

/s/ Jed McCaleb

Name:   Jed McCaleb
Title:   Director

 

ERAS CAPITAL, LLC
By:  

/s/ Andrei Karkar

Name:   Andrei Karkar
Title:   Managing Member

/s/ Ulrich Gall

ULRICH GALL
CHENEL CAPITAL PARTNERS LLC
By:  

/s/ Richard Chenel

Name:   Richard Chenel
Title:   Managing Partner

/s/ Richard Delmas Breezy Wynn

RICHARD DELMAS BREEZY WYNN

Exhibit 99.1

Astra Space, Inc. Announces Closing of Take-Private Transaction

Alameda, California — July 18, 2024 — Astra Space, Inc. (“Astra” or the “Company”) (Nasdaq: ASTR) announced today the successful closing of its take-private transaction.

Under the terms of the definitive agreement for the transaction (the “Merger Agreement”) that was previously announced on March 7, 2024, Apogee Parent, Inc. (“Parent”), an entity formed by Chris Kemp, Astra’s co-founder, chief executive officer and chairman, and Dr. Adam London, Astra’s co-founder, chief technology officer and director, will acquire all of the outstanding shares of the Company’s Class A common stock, par value $0.0001 per share (the “Class A Shares”) not already owned by it for the right to receive $0.50 per share in cash, as more fully described in the Merger Agreement.

With the completion of the take-private acquisition, the Class A Shares ceased trading prior to the opening of trading on July 18, 2024 and will no longer be listed on the Nasdaq Capital Market (“Nasdaq”). The Company also intends to make the applicable filings with the U.S. Securities and Exchange Commission (the “SEC”) to suspend its periodic reporting obligations and to terminate the registration of the Class A Shares underlying the Company’s active registration statements.

As previously disclosed, (i) on April 17, 2024, the Company received a deficiency notice from Nasdaq that the Company is not in compliance with Nasdaq Listing Rule 5450(a)(1) because the per share closing bid price of the Class A Shares had been below $1.00 for thirty consecutive business days prior to such deficiency notice; and (ii) on April 23, 2024, the Company received a deficiency notice from Nasdaq that the Company is not in compliance with the minimum stockholders’ equity listing requirement set forth in Nasdaq Listing Rule 5550(b)(1) because the Company’s Annual Report on Form 10-K for the period ended December 31, 2023, reported stockholders’ equity below $2.5 million.

Advisors

Houlihan Lokey Capital, Inc. served as financial advisor to the Special Committee of the Board of Directors of Astra (the “Special Committee”), and Freshfields Bruckhaus Deringer US LLP served as the Special Committee’s legal counsel. Cozen O’Connor, P.C. served as legal counsel to Astra. Pillsbury Winthrop Shaw Pittman LLP served as legal counsel to Parent and Moelis & Company served as financial advisor to Parent.

About Astra Space, Inc.

Astra’s mission is to improve life on Earth from space by creating a healthier and more connected planet. Today, Astra offers one of the lowest cost-per-launch dedicated orbital launch services, and one of the industry’s leading flight-proven electric propulsion systems for satellites, the Astra Spacecraft Engine.

About Apogee Parent Inc.

Parent was formed solely for the purpose of entering into and consummating the merger with Astra. Parent is owned by a number of long-term investors of Astra and its predecessor, including Mr. Kemp and Dr. London.

Forward Looking Statements

Certain statements made in this press release are “forward-looking statements.” Forward-looking statements may be identified by the use of words such as “anticipate,” “believe,” “expect,” “estimate,” “plan,” “outlook,” and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements reflect the current analysis of existing information and are subject to various risks and uncertainties. As a result, caution must be exercised in relying on forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in these forward-looking statements: (i) the Company’s failure to meet projected development and delivery targets, including as a result of the decisions of governmental authorities or other third parties not within the Company’s control;


(ii) changes in applicable laws or regulations; (iii) the ability of the Company to meet its financial and strategic goals; (iv) the ability of the Company to pursue a growth strategy and manage growth profitability; (v) the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors and (vi) other risks and uncertainties described from time to time in other reports and other public filings with the SEC, including the Company’s registration statements, annual reports and quarterly reports.

Investor Contact:

investors@astra.com

Media Contact:

press@astra.com

v3.24.2
Document and Entity Information
Jul. 18, 2024
Cover [Abstract]  
Security Exchange Name NASDAQ
Amendment Flag false
Entity Central Index Key 0001814329
Current Fiscal Year End Date --12-31
Document Type 8-K
Document Period End Date Jul. 18, 2024
Entity Registrant Name Astra Space, Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-39426
Entity Tax Identification Number 85-1270303
Entity Address, Address Line One 1900 Skyhawk Street
Entity Address, City or Town Alameda
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94501
City Area Code (510)
Local Phone Number 956-5279
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Class A common stock, par value $0.0001 per share
Trading Symbol ASTR
Entity Emerging Growth Company false

Astra Space (NASDAQ:ASTR)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Astra Space Charts.
Astra Space (NASDAQ:ASTR)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Astra Space Charts.